KENNETH WADDELL: Open Payments
NPI 1124504782 · FORSYTH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 62 payments from 17 companies in 2025. Trend: 2023 $1,538 · 2024 $1,529 · 2025 $1,071
Food & beverage: $1,071
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $190 |
| Sumitomo Pharma America, Inc. | 15 | $138 |
| ABBVIE INC. | 3 | $84 |
| Lundbeck LLC | 3 | $82 |
| Lilly USA, LLC | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Phathom Pharmaceuticals, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Noven Therapeutics, LLC | 3 | $46 |
Products named: GEMTESA, REXULTI, Wegovy, VOQUEZNA, Ozempic, TRINTELLIX, VRAYLAR, MOUNJARO.
Industry payments across GA — which companies pay providers there.
